Tenderwize
Back to tender search

Drug discount agreements from 01.07.2025 for various active ingredients under an open-house procedure

AOK NordWest - Die Gesundheitskasse·Dortmund, Germany·Deadline Apr 26, 2027 · 251 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.07.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

30 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to conclude exclusive contracts during the term, which will suspend these open-house agree...

No guaranteed purchase volumes; actual revenue depends on prescriptions and market share.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jun 2027
  • Provide drug discount agreements for the listed active ingredients and combinations.
  • Contract duration up to 24 months from earliest start date 01.07.2025.
Show full summary

The AOK NordWest offers drug discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for multiple active ingredients via an open-house procedure. This is not a public procurement under EU directives but is published for transparency. Qualified pharmaceutical companies can join at any time until the deadline. Contracts start no earlier than 01.07.2025, with a maximum duration of 24 months. No exclusivity is granted; future exclusive contracts may suspend these agreements.

Risks

The buyer reserves the right to conclude exclusive contracts during the term, which will suspend these open-house agree...

No guaranteed purchase volumes; actual revenue depends on prescriptions and market share.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company as defined in §4 Abs. 18 AMG.
  • Must remain a pharmaceutical company for the entire contract duration.

Administrative

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all eligible participants receive a contract.

Buyer

Location

Dortmund, DEU

Website

www.aok.de

Identifier

DE124159739

Activity

Health

Lots (1)

LOT-0001

Drug discount agreements from 01.07.2025 for various active ingredients under an open-house procedure

Open-house procedure for drug discount agreements on multiple active ingredients (Amifampridin, Axitinib, Clindamycin & Benzoylperoxid, Fluorouracil Kombinationen, Folsäure, Imiquimod, Lamivudin & Tenofovirdisoproxil & Doravirin, Lapatinib, Macrogol, Maraviroc, Mesalazin, Peginterferon alfa-2a, Pegvisomant, Pimecrolimus, Raltegravir, Sevelamerhydrochlorid, Xylometazolin). Uniform terms and conditions. No exclusivity. Continuous accession possible.

SuppliesEU fundedElectronic submission

Location

Hagen, Germany

Duration

Jun 2025 - Jun 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all eligible participants receive a contract.

Deadline

Deadline Apr 26, 2027

Procurement Details

Publication date
12 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
306881-2025

Documents (1)

Similar tenders